Meng J, Zhang L, Chen J, Shi W, et al. A prospective phase II trial of hypofractionated stereotactic radiotherapy (FSRT) for patients with 1-10 brain metastases from breast cancer. Int J Radiat Oncol Biol Phys 2025 Dec 24:S0360-3016(25)06606.
PMID: 41453455